The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients

Published:2020-12 Issue:12 Volume:13 Page:100865
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Feng Jiuxing,Chen Shujing,Li Shuangqi,Wu Baitong,Lu Jiacheng,Tan Li,Li Jiamin,Song Yuanlin,Shi Guoming,Shi Yujiang Geno,Jiang Jinjun

Funder

National Natural Science Foundation of China

Shanghai Top-Priority Clinical Key Disciplines Construction Project

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Combining chemotherapy with PD-1 blockade in NSCLC;Mathew;Pharmacol. Ther.,2018

2. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J. Clin. Oncol.,2000

3. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life;Spiro;Thorax,2004

4. Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1-selected advanced non-small-cell lung cancer (BIRCH);Peters;J. Clin. Oncol.,2017

5. Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial;Hui;Ann. Oncol.,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients;Cancers;2023-11-03

2. Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer;Discover Oncology;2023-10-19

3. Role of Next Generation Immune Checkpoint Inhibitor (ICI) Therapy in Philadelphia Negative Classic Myeloproliferative Neoplasm (MPN): Review of the Literature;International Journal of Molecular Sciences;2023-08-07

4. Emerging agents for the treatment of advanced or metastatic NSCLC without actionable genomic alterations with progression on first-line therapy;Expert Review of Anticancer Therapy;2023-07-24

5. Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy;Oncology Letters;2023-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3